SCHEMBL2202034

SCHEMBL2202034

CC(C)(C)OC(=O)N1C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H]1COc1ccccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.39
TSHR P16473 2/20 0.37
ABCB1 P08183 1/20 0.37
SSTR4 P31391 6/20 0.36
SSTR1 P30872 4/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
SRC P12931 4/20 0.36
GRM2 Q14416 1/20 0.36
CACNB4 O00305 1/20 0.35
CACNA1A O00555 1/20 0.35
CACNA1G O43497 1/20 0.35
CACNG3 O60359 1/20 0.35
CACNA1F O60840 1/20 0.35
CACNA1H O95180 1/20 0.35
CACNB3 P54284 1/20 0.35
CACNA2D1 P54289 1/20 0.35
CACNG7 P62955 1/20 0.35
CACNA1B Q00975 1/20 0.35
CACNA1D Q01668 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602385 1.00 GPR119 (0.39) GPR119TSHRABCB1SSTR4SSTR1
SCHEMBL7862914 0.86 ABCB1 (0.41) ABCB1SRC
SCHEMBL3948290 0.86 ABCB1 (0.41) ABCB1SRC
SCHEMBL2200981 0.83 ABCB1 (0.39) GPR119ABCB1SSTR4SSTR1SRC
SCHEMBL2201807 0.83 POLB (0.42) GPR119TSHRSSTR4SSTR1SRC
SCHEMBL4603500 0.83 POLB (0.42) GPR119TSHRSSTR4SSTR1SRC
SCHEMBL2547741 0.82 ITGA4 (0.41) GPR119SSTR4SSTR1GRM2
SCHEMBL1241283 0.81 GPR119 (0.39) GPR119ABCB1SRCMEN1KMT2A
SCHEMBL3955172 0.81 HDAC8 (0.38) GPR119ABCB1ALDH1A1
SCHEMBL4292542 0.80 ABCB1 (0.47) GPR119ABCB1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912994-B1 ADENINE DERIVATIVES MERCK PATENT GMBH (DE) 2014-03-12 EP disclosed
US-7977343-B2 Adenine derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-07-12 US disclosed
US-20100160352-A1 ADENINE DERIVATIVES MERCK PATENT GMBH (DE) 2010-06-24 US disclosed
EP-1912994-A1 ADENINE DERIVATIVES Merck Patent GmbH (DE) 2008-04-23 EP disclosed
WO-2007017069-A1 ADENINE DERIVATIVES MERCK PATENT GMBH (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160352-A1 ADENINE DERIVATIVES HSP90AA1, TRAP1, HSP90AB1 GPR119 2275/4885TSHR 3888/4885ABCB1 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.